Nature's Toolbox key facts
as of Oct 2026- Developer of a scalable biomanufacturing platform designed to transform the healthcare industry through eco-friendly production of lifesaving therapies.
- Nature's Toolbox is valued at approximately $71.0M as of Oct 2026, set at its later-stage round, Feb 2026; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $85.9M across 5 recorded rounds; the latest was Early Stage VC ($10.4M) in Nov 2025.
- Notable investors include RA Capital Management, Anzu Partners, BlueStone Venture Partners, Camino Real Capital Partners, High Desert Discovery District — 10 tracked in total.
- Nature's Toolbox has filed 4 Form Ds with the SEC since 2020, most recently May 2025 ($4.2M sold to 14 investors).
- Status: Privately Held (backing).
Valued at $71.0M at its later-stage round, Feb 2026. Nothing has traded since.
- ·Watch Nature's Toolbox: the Monday email on marks, rounds and moves
Nature's Toolbox funding rounds
5 roundsWho backs Nature's Toolbox
10Nature's Toolbox valuation
Nature's Toolbox was valued at $71 million at its later-stage round in Feb 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Nature's Toolbox raised?
Nature's Toolbox has raised $85.9 million across 5 recorded rounds since 2020. The largest was a $47.5 million Series B in Nov 2023; the most recent was a $10.4 million early-stage round in Nov 2025.
Nature's Toolbox has filed 4 Form Ds with the SEC since 2020, most recently in May 2025 ($4.2 million sold to 14 investors).
Nature's Toolbox investors
10 investors are on record for Nature's Toolbox, including RA Capital Management, Anzu Partners, BlueStone Venture Partners and Camino Real Capital Partners. The early-stage round in Nov 2025 drew 19 investors.
Comparable companies
Comparable discovery tools (healthcare) names by valuation on PrivateMarketView: Vitrivax ($69.4 million), Xcell Biosciences ($65.5 million) and Algen ($24 million).
About Nature's Toolbox
Developer of a scalable biomanufacturing platform designed to transform the healthcare industry through eco-friendly production of lifesaving therapies. The company's platform offers adaptable systems for personalized and large-scale therapy production to create life-saving medicines in an eco-friendly and sustainable way, enabling oncology, rare disease and other therapeutic fields to access efficient and sustainable biomanufacturing.
- Industry
- Discovery Tools (Healthcare)
- Sector
- Healthcare
- HQ
- Rio Rancho, NM, United States
- Founded
- 2015
- Employees
- 47
- Website
- ntxbio.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.